Physician profile
Miers C Johnson
NPI 1942291521
$18,043.11
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2021: $945 · 2022: $2,795 · 2023: $1,833 · 2024: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169 · Travel and Lodging: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.79 |
| Travel and Lodging | $879.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $13,244.68 | 2019-2022 | |
| Arthrex, INC. | $2,262.72 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $817.22 | 2021 | |
| Stryker Corporation | $538.58 | 2019-2024 | Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Augmented Glenoid |
| Steelhead Surgical INC | $416.20 | 2021-2023 | |
| Depuy Synthes Sales INC. | $221.12 | 2019 | |
| Medical Device Business Services, INC. | $191.65 | 2019-2022 | |
| Shoulder Innovations, INC. | $166.10 | 2023-2024 | Inset System |
| Pacira Pharmaceuticals Incorporated | $38.19 | 2022-2023 | Exparel, Zilretta, Iovera |
| Smith+Nephew, INC. | $34.21 | 2022-2023 | Or3o Dual Mobility |
| Heron Therapeutics, INC. | $31.30 | 2021-2022 | |
| Acumed LLC | $24.56 | 2023 | Acumed |
| Bioventus LLC | $22.41 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.52 | 2024 | Euflexxa |
| Baxter Healthcare | $14.65 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miers Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.